ABBV - Wells and BMO cut views on Gilead in premarket analyst action April, 20 2020 07:05 AM AbbVie Inc. Benitec Biopharma Limited (NASDAQ:BNTC) initiated with Buy rating and $14 (140% upside) price target at Ladenburg Thalmann.More news on: Benitec Biopharma Limited, AbbVie Inc., Gilead Sciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...